19
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1511 | Daunorubicin hydrochloride | Daunomycin HCl,RP-13057 Hydrochloride,Rubidomycin hydrochloride,Daunorubicin HCl,Daunomycin | Apoptosis , DNA/RNA Synthesis , Topoisomerase , Antibacterial , Antibiotic , Autophagy |
Daunorubicin hydrochloride (Rubidomycin hydrochloride), an anthracycline aminoglycoside antineoplastic, inhibits DNA replication and repair and RNA and protein synthesis. | |||
T29825 | Alanylleucyl-daunorubicin | ||
Alanylleucyl-daunorubicin is a biochemical. | |||
T25291 | Daunosamnyl-daunorubicin | ||
Daunosamnyl-daunorubicin is used as an antibody conjugate. | |||
T73700 | Daunorubicin citrate | ||
Daunorubicin (Daunomycin) citrate, a potent anti-tumor anthracycline antibiotic, acts as a topoisomerase II inhibitor. It effectively inhibits DNA and RNA synthesis, diminishes cancer cell viability, and promotes apoptos... | |||
T72115 | 5-Iminodaunorubicin hydrochloride | ||
5-Iminodaunorubicin hydrochloride, a quinone-modified anthracycline, maintains antitumor efficacy. It induces concealed DNA strand breaks within cancer cells, mediated by protein interactions. | |||
T18317 | MCC-Modified Daunorubicinol | Others | |
Daunorubicinol, a potent antitumor drug-linker conjugate for antibody-drug conjugate (ADC) applications, utilizes Aur0101 (DNA Topoisomerase II inhibitor) connected through the ADC linker[1]. | |||
T72467 | 5-Iminodaunorubicin | ||
5-Iminodaunorubicin, a quinone-modified anthracycline, maintains antitumor activity by inducing concealed DNA strand breaks within cancer cells' proteins. | |||
T31209 | Daunorubicinol | Duborimycin,Antibiotic 20-798RP | |
Daunorubicinol is the main metabolite of daunomycin. | |||
TN2496 | 1,4-Anthraquinone | Others | |
1,4-Anthraquinone is an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar ... | |||
T15054 | Daun02 | Topoisomerase | |
Daun02 is the topoisomerase inhibitor Daunorubicin prodrug. | |||
T26161 | Ruboxyl | Ruboxyl hydrochloride | |
Ruboxyl, a nitroxylated analog of daunorubicin, is an anthracycline antibiotic. | |||
T31088 | CPX-351 | Cytarabine/daunonubicin,Vyxeos,CPX 351,Daunonubicin/cytarabine | |
CPX-351 is a Liposomal-encapsulated combination of daunorubicin and cytarabine for the treatment of newly diagnosed tAML or AML with myelodysplasia-related changes (AML-MRCs). | |||
T31468 | Dihydrodaunomycin HCl | Dihydrodaunomycin hydrochloride,Antibiotic RP 20798,RP20798,RP-20798,RP 20798 | |
Dihydrodaunomycin HCl is a metabolite of Daunorubicin. | |||
T68948 | Detorubicin HCl | ||
Detorubicin is a semi-synthetic derivative of the anthracycline antineoplastic antibiotic daunorubicin. Detorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair... | |||
T68909 | Detorubicin Free Base | ||
Detorubicin Free Base is a semi-synthetic derivative of the anthracycline antineoplastic antibiotic daunorubicin. Detorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication ... | |||
T69130 | Zorubicin | Rubidazon ; Rubidazone,Rubidazone,Rubidazon | |
Zorubicin (Rubidazon), a Daunorubicin derivative, inhibits DNA polymerases and interacts with topoisomerase II. It is utilized in the research of acute leukemias and sarcomas [1] [2] [3] [4] [5]. | |||
T37068 | NR-160 | ||
NR-160 is an inhibitor of histone deacetylase 6 (HDAC6; IC50= 0.03 μM).1It is selective for HDAC6 over HDAC1, -2, -3, -4, and -8 (IC50s = 5.18, 2.26, 8.48, 55.4, and 14.7 μM, respectively). NR-160 is cytotoxic against a ... | |||
T37851 | Chlorido[N,N'-disalicylidene-1,2-phenylenediamine]iron(III) | ||
Chlorido[N,N'-disalicylidene-1,2-phenylenediamine]iron(III) is an inducer of ferroptosis.1 It induces ferroptosis, but not apoptosis or necroptosis, in NB1 cancer cells when used at a concentration of 3 μM.1 Chlorido[N,N... | |||
T35696 | Olomoucine II | ||
Olomoucine II is an inhibitor of cyclin-dependent kinases (CDKs; IC50s = 7.6, 0.1, 19.8, 0.45, and 0.06 μM for Cdk1, -2, -4, -7, and -9, respectively).1It is selective for CDKs over 10 additional kinases (IC50s = >100 μM... |